REGEN-Cov antibody combination to prevent COVID-19 infection in kidney transplant recipient without detectable antibody response to optimal vaccine scheme

Kidney Int. 2022 Mar;101(3):645-646. doi: 10.1016/j.kint.2021.12.015. Epub 2022 Jan 4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neutralizing
  • Antibody Formation
  • COVID-19 Vaccines*
  • COVID-19*
  • Drug Combinations
  • Humans
  • Kidney Transplantation*
  • SARS-CoV-2
  • Transplant Recipients

Substances

  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neutralizing
  • COVID-19 Vaccines
  • Drug Combinations
  • casirivimab and imdevimab drug combination